Dr. Michael McCarthy:

In my experience, I did not go down the full list, but recently, immunotherapy for concurrent chemo-radiotherapy and cervical cancer patients treated curatively has been shown to be beneficial and, similarly, for head and neck cancer for patients with curative intent. For my patients, I would estimate that maybe 20% to 30% of patients fall into that category-----